Cannabis use and psychosis: a review of clinical and epidemiological evidence*

References

• Hall W, Solowij N, Lemon L. The health and psychological effects of cannabis use. National Drug Strategy Monograph Series No. 25, Australian Government Publication Service, Canberra 1994
   Google Scholar
• Hall W. A simplified logic of causal inference. Australian and New Zealand Journal of Psychiatry 1987; 21: 507–513
   PubMed Web of Science ®Google Scholar
• Bernardson G, Gunne LM. Forty‐six cases of psychosis in cannabis abusers. International Journal of Addictions 1972; 7: 9–16
   PubMedGoogle Scholar
• Chopra GS, Smith JW. Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry 1974; 30: 24–27
   PubMed Web of Science ®Google Scholar
• Solomons K, Neppe VM, Kuyl JM. Toxic cannabis psychosis is a valid entity. South African Medical Journal 1990; 78: 476–481
   PubMed Web of Science ®Google Scholar
• Wylie AS, Scott RTA, Burnett SJ. Psychosis due to ‘skunk’. British Medical Journal 1995; 311: 125
   PubMed Web of Science ®Google Scholar
• Harding T, Knight F. Marijuana‐modified mania. Archives of General Psychiatry 1973; 29: 635–637
   PubMed Web of Science ®Google Scholar
• Eva J. Cannabis psychosis. Psychiatric Bulletin 1992; 16: 310–311
   Google Scholar
• Carney MWP, Bacelle L, Robinson B. Psychosis after cannabis use. British Medical Journal 1984; 288: 1047
   PubMed Web of Science ®Google Scholar
• Tennant FS, Groesbeck CJ. Psychiatric effects of hashish. Archives of General Psychiatry 1972; 27: 133–136
   PubMed Web of Science ®Google Scholar
• Hall W. Cannabis and psychosis. Drug and Alcohol Review 1998; 17: 433–444
   PubMed Web of Science ®Google Scholar
• Thornicroft G. Cannabis and psychosis: is there epidemiological evidence for association. British Journal of Psychiatry 1990; 157: 25–33
   PubMed Web of Science ®Google Scholar
• Gruber AJ, Pope HG. Cannabis psychotic disorder. Does it exist?. American Journal of the Addictions 1994; 3: 72–83
   Web of Science ®Google Scholar
• Thacore VR, Shukla SRP. Cannabis psychosis and paranoid schizophrenia. Archives of General Psychiatry 1976; 33: 383–386
   PubMed Web of Science ®Google Scholar
• Rottanburg D, Robins AH, Ben‐Arie O, Teggin A, Elk R. Cannabis‐associated psychosis with hypomanic features. Lancet 1982; 2: 1364–1366
   PubMed Web of Science ®Google Scholar
• Imade AGT, Ebie JC. A retrospective study of symptom patterns of cannabis‐induced psychosis. Acta Psychiatrica Scandinavica 1991; 83: 134–136
   PubMed Web of Science ®Google Scholar
• McGuire P, Jones R, Harvey I, et al. Cannabis and acute psychosis. Schizophrenia Research 1994; 13: 161–168
   PubMed Web of Science ®Google Scholar
• McGuire P, Jones R, Harvey I, Williams M, McGuffin P, Murray R. Morbid risk of schizophrenia for relatives of patients with cannabis associated psychosis. Schizophrenia Research 1995; 15: 277–281
   PubMed Web of Science ®Google Scholar
• Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. Journal of Nervous and Mental Disease 1990; 178: 473–480
   PubMed Web of Science ®Google Scholar
• Thomas H. A community survey of adverse effects of cannabis use. Drug and Alcohol Dependence 1996; 42: 201–207
   PubMed Web of Science ®Google Scholar
• Hall W, Teesson M, Lynskey M, Degenhardt L. The prevalence in the past year of substance use and ICD‐10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well‐being. National Drug and Alcohol Research Centre, Sydney 1998, Technical Report No. 63
   Google Scholar
• Poole R, Brabbins C. Drug induced psychosis. British Journal of Psychiatry 1996; 168: 135–138
   PubMed Web of Science ®Google Scholar
• Schneier FR, Siris SG. A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disorders 1987; 175: 641–652
   PubMed Web of Science ®Google Scholar
• Smith J, Hucker S. Schizophrenia and substance abuse. British Journal of Psychiatry 1994; 165: 13–21
   PubMed Web of Science ®Google Scholar
• Warner R, Taylor D, Wright J, et al. Substance use among the mentally ill: prevalence, reasons for use and effects on illness. American Journal of Orthopsychiatry 1994; 74: 30–39
   Web of Science ®Google Scholar
• Mueser KT, Bellack AS, Blanchard JJ. Comorbidity and substance abuse: implications for treatment. Journal of Consulting and Clinical Psychology 1992; 60: 845–856
   PubMed Web of Science ®Google Scholar
• Cuffel BJ. Prevalence estimates of substance abuse in schizophrenia and their correlates. Journal of Nervous and Mental Disease 1992; 180: 589–592
   PubMed Web of Science ®Google Scholar
• Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin 1990; 16: 31–56
   PubMed Web of Science ®Google Scholar
• Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40: 1155–1163
   PubMed Web of Science ®Google Scholar
• Donnelly N, Hall W. Patterns of cannabis use in Australia. National Drug Strategy Monograph Series No. 27, Australian Government Publication Service, Canberra 1994
   Google Scholar
• Dixon L, Haas G, Wedien PJ, Sweeney J, Frances AJ. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self‐reports. Schizophrenia Bulletin 1990; 16: 69–79
   PubMed Web of Science ®Google Scholar
• Arndt S, Tyrrell G, Flaum M, Andreasen NC. Comorbidity of substance abuse and schizophrenia: the role of premorbid adjustment. Psychological Medicine 1992; 22: 379–388
   PubMed Web of Science ®Google Scholar
• Cuffel BJ, Heithoff KA, Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hospital and Community Psychiatry 1993; 44: 247–251
   PubMedGoogle Scholar
• Kovasznay B, Bromet E, Schwartz JE, Ram R, Lavelle J, Brandon L. Substance abuse and onset of psychotic illness. Hospital and Community Psychiatry 1993; 44: 567–571
   PubMedGoogle Scholar
• Zisook S, Heaton R, Moranville J, Kuck J, Jernigan T, Braff D. Past substance abuse and clinical course of schizophrenia. American Journal of Psychiatry 1992; 149: 552–553
   PubMed Web of Science ®Google Scholar
• Anthony JC, Helzer JE. Syndromes of drug abuse and dependence. Psychiatric Disorders in America: the Epidemiological Catchment Area study, LN Robins, DA Regier. Free Press, New York 1991
   Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association 1990; 264: 2511–2518
   PubMed Web of Science ®Google Scholar
• Helzer JE, Burnam A, McEvoy LT. Alcohol abuse and dependence. Psychiatric Disorders in America: the epidemiologic catchment area study, LN Robins, DA Regier. Free Press, New York, NY 1991
   Google Scholar
• Bland RC, Newman SC, Orn H. Schizophrenia: lifetime co‐morbidity in a community sample. Acta Psychiatrica Scandinavica 1987; 75: 383–391
   PubMed Web of Science ®Google Scholar
• Allebeck P. Cannabis and schizophrenia: is there a causal association?. Physiopathology of illicit drugs: cannabis, cocaine, opiates, GG Nahas, C Latour. Pergamon, Oxford 1991
   Google Scholar
• Bromet EJ, Dew A, Eaton W. Epidemiology of psychosis with special reference to schizophrenia. Textbook in psychiatric epidemiology, MT Tsuang, M Tohen, GEP Zahner. John Wiley, New York, NY 1995
   Google Scholar
• Andreassom S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483–1486
   PubMed Web of Science ®Google Scholar
• Negrete JC. Cannabis and schizophrenia. British Journal of Addiction 1989; 84: 349–351
   PubMedGoogle Scholar
• Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. Acta Psychiatrica Scandinavica 1989; 79: 505–510
   PubMed Web of Science ®Google Scholar
• Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Archives of General Psychiatry 1975; 32: 923–932
   PubMed Web of Science ®Google Scholar
• Bell D. The experimental reproduction of amphetamine psychosis. Archives of General Psychiatry 1973; 29: 35–40
   PubMed Web of Science ®Google Scholar
• Inghe G. The present state of abuse and addiction to stimulant drugs in Sweden. Abuse of central stimulants, F Sjoqvist, M Tottie. Raven, New York, NY 1969
   Google Scholar
• Connell PH. Amphetamine psychosis. Institute of Psychiatry, London 1958
   Google Scholar
• Weil A. Adverse reactions to marihuana. New England Journal of Medicine 1970; 282: 997–1000
   PubMed Web of Science ®Google Scholar
• Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin 1990; 16: 81–85
   PubMed Web of Science ®Google Scholar
• Turner WM, Tsuang MT. Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bulletin 1990; 16: 87–372
   PubMed Web of Science ®Google Scholar
• Negrete JC, Knapp WP, Douglas D, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine 1986; 16: 515–520
   PubMed Web of Science ®Google Scholar
• Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 1991; 52: 26–30
   PubMed Web of Science ®Google Scholar
• Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten‐Country Study. 1991, Psychological Medicine Monograph Supplement No. 20
   Google Scholar
• Martinez‐Arevalo MJ, Calcedo‐Ordonez A, Varo‐Prieto JR. Cannabis consumption as a prognostic factor in schizophrenia. British Journal of Psychiatry 1994; 164: 679–681
   PubMed Web of Science ®Google Scholar
• Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent‐onset schizophrenic disorders. Archives of General Psychiatry 1994; 51: 273–279
   PubMed Web of Science ®Google Scholar
• Heather N, Tebbutt J. The effectiveness of treatment for drug and alcohol problems: an overview. National Campaign Against Drug Abuse Monograph Series No. 11, Australian Government Publishing Service, Canberra 1989
   Google Scholar
• Kavanagh DJ. An intervention for substance abuse in schizophrenia. Behaviour Change 1995; 12: 20–30
   Web of Science ®Google Scholar
• Lehman AF, Herron JD., Schwartz RP, Myers CP. Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease 1993; 181: 86–90
   PubMed Web of Science ®Google Scholar
• Jerrell J, Ridgely MS. Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease 1995; 183: 566–576
   PubMed Web of Science ®Google Scholar
• Noordsy DL, Drake RE, Teague GB, et al. Subjective experiences related to alcohol use among schizophrenics. Journal of Nervous and Mental Disease 1991; 179: 410–414
   PubMed Web of Science ®Google Scholar
• Test MA, Wallisch LS, Allness DJ, Tripp K. Substance use in young adults with schizophrenic disorders. Schizophrenia Bulletin 1989; 15: 465–476
   PubMed Web of Science ®Google Scholar
• Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatrica Scandinavica 1992; 85: 127–130
   PubMed Web of Science ®Google Scholar
• Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine and caffeine use and symptom distress in schizophrenia. Journal of Nervous and Mental Disease 1995; 183: 559–565
   PubMed Web of Science ®Google Scholar
• Stahl SM. Essential psychopharmacology. Cambridge University Press, Cambridge 1996
   Google Scholar
• Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996; 91: 1585–1614
   PubMed Web of Science ®Google Scholar
• Gottesman II. Schizophrenia genesis: the origins of madness. W.H. Freeman, New York, NY 1991
   Google Scholar
• Der G, Gupta S, Murray RM. Is schizophrenia disappearing?. Lancet 1990; 1: 513–516
   Web of Science ®Google Scholar
• Kendell RE, Malcolm DE, Adams W. The problem of detecting changes in the incidence of schizophrenia. British Journal of Psychiatry 1993; 162: 212–218
   PubMed Web of Science ®Google Scholar
• Joyce PR. Changing trends in first admissions and readmissions for mania and schizophrenia in New Zealand. Australian and New Zealand Journal of Psychiatry 1987; 21: 82–86
   PubMed Web of Science ®Google Scholar